Glaukos

GKOS NYSE
77.10
+1.92
+2.55%
交易中 15:15 06/18 EDT
开盘
75.92
昨收
75.18
最高
78.49
最低
75.85
成交量
25.95万
成交均量(3M)
38.89万
52周最高
83.14
52周最低
36.89
换手率
0.71%
市值
28.07亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Glaukos GKOS股票价格,Glaukos股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm's canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream. It is developing three additional pipeline products: the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is a drug delivery system that is designed to be implanted in the eye to continuously deliver therapeutic levels of medication for extended periods of time to lower intraocular pressure in glaucoma patients.
展开 >

最近浏览

名称
价格
涨跌幅